e Window trial to evaluate molecular response of PI3K inhibition with copanlisib in relapsed or refractory adult B-cell acute lymphoblastic leukemia
Clinical Trial Grant
Awarded By
Bayer HealthCare, LLC
Start Date
April 26, 2021
End Date
May 14, 2026
Awarded By
Bayer HealthCare, LLC
Start Date
April 26, 2021
End Date
May 14, 2026